Autoimmune Glial Fibrillary Acidic Protein (GFAP) Astrocytopathy in a Kidney Transplant Recipient (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #SA-PO1205; Pres time: Oct 24, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "Cyclosporine was discontinued, and prednisone taper continued with gradual neurologic recovery...Management includes corticosteroids, IVIG, plasma exchange, and rituximab... GFAP astrocytopathy is a rare but important cause of encephalopathy in renal transplant recipients. Diagnosis requires high clinical suspicion and systematic evaluation. Management is challenging, requiring multidisciplinary coordination to balance immunologic treatment with infection risk and graft outcomes."
Clinical • CNS Disorders • Epilepsy • Genito-urinary Cancer • Glomerulonephritis • Herpes Zoster • IgA Nephropathy • Immunology • Infectious Disease • Nephrology • Novel Coronavirus Disease • Renal Cell Carcinoma • Solid Tumor • Transplantation • Varicella Zoster • GFAP
|
|
Srilekha Sridhara; Bassam G. Abu Jawdeh; Sami Alasfar; Sumi Nair; Hay Me Me
|